According to GlobalData’s medical device pipeline database, 25 IM Nails devices are in various stages of development globally. GlobalData’s report IM Nails provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Innovations in IM Nails - Global Pipeline Summary

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Of these devices, 11 are in active development, while the remaining 14 are in an inactive stage of development. There are four products in the early stages of development, and the remaining seven are in the late stages of development.

Intramedullary (IM) Nails are used in trauma fixation procedures to align and stabilize fractures such as humeral, tibial and femoral, sternum, and hip fractures. IM nails are inserted in the medullary cavity in the center of the long bones. They are made of cobalt-chromium-molybdenum, stainless steel, or titanium. One unit includes one IM nail and four Screws/ bolts.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed IM Nails pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of IM Nails devices. Overall, most of these IM Nails pipeline devices are being developed by private entities.

Key players involved in the active development of IM Nails include Resoimplant, Implants International, OrthoPediatrics, Response Ortho, Saint Louis University, SUNY Upstate Medical University, Teleflex, University of Massachusetts Worcester Campus, University of North Carolina at Chapel Hill and Wake Forest School of Medicine.

For a complete picture of the developmental pipeline for IM Nails devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.